|
|
|
|
Canton student conducts breast cancer survivor research - Canton Journal http://bit.ly/ai0QAa |
| BIClinicalTrial, 1 day ago from twitterfeed |
|
|
|
|
'Major advance' in tackling aggressive breast cancer http://bit.ly/bp0U1T |
| Hamner Institutes, 2 days ago from TweetDeck |
|
|
|
|
Clinical Breast Cancer (Vol 10, Supp 2) now available at www.cigjournals.com. Direct link to TOC: http://tinyurl.com/2e5kkdc #breastcancer |
| CIG Media Group, 3 days ago from web |
|
|
|
|
Targeted strategies needed to find, prevent and treat breast cancer among ... - EurekAlert (press release) http://bit.ly/dzqj6c |
| BIClinicalTrial, 4 days ago from twitterfeed |
|
|
|
|
FDA's decision on Avastin is a personal one for breast cancer patients - Tampabay.com http://bit.ly/abUGq5 |
| BIClinicalTrial, 6 days ago from twitterfeed |
|
|
|
|
Eisai Announces 3 month Extension of FDA PDUFA Date of NDA for Eribulin Mesylate indicated 4 breast cancer http://ow.ly/2wHIC |
| eyeonfda, 6 days ago from HootSuite |
|
|
|
|
FDA kicks breast cancer drug back to Genentech http://bit.ly/dehHi6 |
| Pharma Marketer, 1 week ago from twitterfeed |
|
|
|
|
24-hour test to reveal whether breast cancer drug works - Daily Mail http://bit.ly/bBMz2r |
| BIClinicalTrial, 1 week ago from twitterfeed |
|
|
|
|
RT @MaverickNY: My take on the FDA rejection of Roche's T-DM1 filing in metastatic breast cancer: http://bit.ly/aE0leJ $RHHBY $IMGN #hcsmeu |
| Angel Gonzalez, 1 week ago from TweetDeck |
|
|
|
|
My take on the FDA rejection of Roche's T-DM1 filing in metastatic breast cancer: http://bit.ly/aE0leJ $RHHBY $IMGN |
| Sally Church, 1 week ago from bitly |
|
|
|
|
Not breastfeeding increases mothers' risk for type 2 diabetes: The benefits of breastfeeding for babies have pro... http://bit.ly/aNP80Q |
| Pharma Biotech Tech, 1 week ago from twitterfeed |
|
|
|
|
Not breastfeeding increases mothers' risk for type 2 diabetes: The benefits of breastfeeding for babies have pro... http://bit.ly/aNP80Q |
| Pharma Biotech Tech, 1 week ago from twitterfeed |
Rss Feed
